The incidences of nausea and vomiting after general anesthesia with remimazolam versus sevoflurane: a prospective randomized controlled trial
Korean Journal of Anesthesiology · 2024
DOI: 10.4097/kja.23939 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Korean Journal of Anesthesiology, 2024. Verfasst von Yeong Min Yoo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea. Hauptthemen laut MEDLINE: Postoperative Nausea and Vomiting, Sevoflurane, Anesthesia, General, Anesthetics, Inhalation. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pusan National University.
Abstract (Originalsprache)
Background
Postoperative nausea and vomiting (PONV) refers to nausea and vomiting that occurs within 24-h after surgery or in the post-anesthesia care unit (PACU). Previous studies have reported that the use of remimazolam, a newer benzodiazepine (BDZ) hypnotic, for anesthesia results in less PONV. In this study, we compared the rate of PONV between sevoflurane and remimazolam after general anesthesia.
Methods
In this prospective randomized controlled trial, participants aged 20–80 years who underwent elective laparoscopic cholecystectomy or hemicolectomy were randomized to either the remimazolam or sevoflurane group. The primary outcome was PONV incidence for 24-h after surgery. Secondary outcomes comprised of PONV at 30-min post-surgery, postoperative additional antiemetic use, and Quality of Recovery-15 (QOR-15) score at 24-h postoperatively.
Results
Forty patients were enrolled in the study. The remimazolam group exhibited significantly lower rates of PONV for 24-h after surgery than did the sevoflurane group (remimazolam group vs. sevoflurane group; 5% vs. 45%, P = 0.003, respectively). The use of dexamethasone, a rescue antiemetic administered within 24 h of surgery, was substantially lower in the remimazolam group than in the sevoflurane group (0% in remimazolam vs. 30% in sevoflurane, P = 0.020). The QOR-15 score at 24-h after surgery showed no significant difference between the two groups.
Conclusions
Compared to sevoflurane, opting for remimazolam as an intraoperative hypnotic may decrease the incidence of PONV and reduce antiemetic use for 24 h after laparoscopic surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia and Pain Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
- Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Busan, Korea.
- Department of Anesthesiology and Pain Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
Förderung
- Pusan National University
Zitieren
APA
Yoo, Y. M., Park, J. H., Lee, K. H., Yi, A. H., & Kim, T. K. (2024). The incidences of nausea and vomiting after general anesthesia with remimazolam versus sevoflurane: a prospective randomized controlled trial. Korean Journal of Anesthesiology. https://doi.org/10.4097/kja.23939
Vancouver
Yoo YM, Park JH, Lee KH, Yi AH, Kim TK. The incidences of nausea and vomiting after general anesthesia with remimazolam versus sevoflurane: a prospective randomized controlled trial. Korean Journal of Anesthesiology. 2024. doi:10.4097/kja.23939
BibTeX
@article{Yoo2024,
author = {Yoo, Yeong Min and Park, Jae Hong and Lee, Ki Hwa and Yi, Ah Hyeon and Kim, Tae Kyun},
title = {The incidences of nausea and vomiting after general anesthesia with remimazolam versus sevoflurane: a prospective randomized controlled trial},
journal = {Korean Journal of Anesthesiology},
year = {2024},
doi = {10.4097/kja.23939}
}
EUVIMED